Home

The Cutting Edge of MM: The Evolving Role of CD38-directed Strategies

Podcast Series

The Role of the ED in Treating Multiple Myeloma in the Era of Novel Immunotherapies

Joshua Richter, MD; Monica Wattana, MD, FAAEM; and Larysa Sanchez, MD

PODCAST DISCUSSION - The Role of the ED in Treating Multiple Myeloma in the Era of Novel Immunotherapies

Joshua Richter, MD; Monica Wattana, MD, FAAEM; and Larysa Sanchez, MD

Trending Now

The Role of the ED in Treating Multiple Myeloma in the Era of Novel Immunotherapies

Joshua Richter, MD; Monica Wattana, MD, FAAEM; and Larysa Sanchez, MD

Beginning the MM Journey: CD38-targeting Agents in the Frontline Treatment Setting

Joshua Richter, MD, FACP and Andrew Yee, MD

The MM Journey Continues: CD38-targeting Agents in the Relapsed/Refractory Setting

Joshua Richter, MD, FACP and Andrew Yee, MD

How the Journey Might Change: Emerging Concepts, Future Directions and CD38-targeting Agents in MM

Joshua Richter, MD, FACP and Andrew Yee, MD

MO Signup MailChimp

MediCom Worldwide, Inc. Links

ManagingAML.com | ManagingMDS.com | ManagingMPN.com | ManagingLymphoma.com | PracticalOncologist.com | PracticalHematologist.com | ManagingCVD.com | ManagingSCD.com | MediComWorldwide.com